Moderna reiterates 10% revenue-growth target as Covid vaccine demand falls

Moderna reported falling fourth-quarter sales as Covid-19 vaccine demand continued to drop, but continues to target 10% ...
Fierce Pharma

With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment

Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior ...
STAT

FDA’s rejection of Moderna threatens to stifle broader vaccine industry

Experts say the FDA "moved the goalposts" on Moderna, creating "a destructive precedent that will undermine the future of vaccine development" in the U.S.

Moderna says FDA refuses its application for new mRNA flu vaccine

Moderna received a refusal-to-file letter from the FDA objecting to how it conducted a 40,000-person trial comparing its new ...

Moderna stock sinks on vaccine rejection. Company is 'desperately seeking clarification.'

The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu ...